Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
1.170
+0.010 (0.86%)
At close: Nov 20, 2024, 4:00 PM
1.220
+0.050 (4.27%)
After-hours: Nov 20, 2024, 7:06 PM EST
Unity Biotechnology Employees
Unity Biotechnology had 19 employees as of December 31, 2023. The number of employees decreased by 13 or -40.63% compared to the previous year.
Employees
19
Change (1Y)
-13
Growth (1Y)
-40.63%
Revenue / Employee
n/a
Profits / Employee
-$1,152,105
Market Cap
19.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Pieris Pharmaceuticals | 50 |
VSee Health | 40 |
American Shared Hospital Services | 31 |
Movano | 30 |
Spruce Biosciences | 29 |
MEI Pharma | 28 |
iBio, Inc. | 16 |
NeuroBo Pharmaceuticals | 8 |
UBX News
- 16 days ago - UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 3 months ago - UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 4 months ago - UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer - GlobeNewsWire
- 6 months ago - UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 7 months ago - UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting - GlobeNewsWire
- 7 months ago - UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME - GlobeNewsWire
- 7 months ago - UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 10 months ago - New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss - GlobeNewsWire